Abstract:Unbiased long read sequencing approaches for clinical metagenomic sample analysis holds enormous potential for pathogen detection, including improved detection of unknown, novel or emerging viruses. However, the rapid rate of development in nanopore sequencing and library preparation methods complicates the process of selecting a standardized method for unbiased RNA virus detection. Here, we evaluate multiple sequencing approaches to identify a workflow with sufficient sensitivity, limits of detection, and throughput for potential utilization in a clinical laboratory setting. Four separate library preparation methods for the Oxford Nanopore Technologies MinION sequencer are compared, including direct RNA, direct cDNA, rapid cDNA, and double stranded cDNA. We also establish that depletion of host RNA is not required and can be deleterious for viral RNA detection in some instances when using samples in viral transport media (VTM) or plasma. Using unbiased whole genome amplification following reverse transcription, we achieve limits of detection on the order of 1.95E03 GE/mL of Venezuelan Equine Encephalitis Virus (VEEV) spiked in human plasma. We also report initial detection of 5.43E06 GE/mL of coronavirus 229E spiked into VTM samples containing human background RNA which are expected to decrease significantly during upcoming testing. These metrics were achieved within a 6-plex multiplex reaction, illustrating the potential to increase throughput and decrease costs for relevant sample analysis. Data analysis was performed using EPI2ME Labs framework and open access tools that are readily accessible to most clinical laboratories. Taken together, this work describes an optimized method for unbiased nanopore sequencing and analysis of RNA viruses present in two common clinical matrices.

Single molecule sequencing of the M13 virus genome without amplification

Single molecule sequencing of M13 virus genome without amplification

Resequencing the Escherichia coli genome by GenoCare single molecule sequencing platform

A Two-color Single-molecule Sequencing Platform and Its Clinical Applications

Genome sequencing in microfabricated high-density picolitre reactors

Single molecule, near full-length genome sequencing of dengue virus

A single-molecule nanopore sequencing platform

Enrichment of long DNA fragments from mixed samples for Nanopore sequencing

Construction of a Sensing Platform Based on DNA-Encoded Magnetic Beads and Copper Nanoclusters for Viral Gene Analysis with Target Recycling Amplification

Direct next-generation sequencing of virus-human mixed samples without pretreatment is favorable to recover virus genome

Rapid High-Throughput Whole-Genome Sequencing of SARS-CoV-2 by Using One-Step Reverse Transcription-PCR Amplification with an Integrated Microfluidic System and Next-Generation Sequencing

Motor Protein-Assisted Glycan Translocation and Sequencing Using Nanopores

A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification

Accurate viral genome reconstruction and host assignment with proximity-ligation sequencing

Advances in Nanopore and Photoelectron-Based High-Throughput Sequencing Technology for Single-Molecule Sequencing

MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution

Unbiased metagenomic detection of RNA viruses for rapid identification of viral pathogens in clinical samples

An Ultralocalized Cas13a Assay Enables Universal and Nucleic Acid Amplification-Free Single-Molecule RNA Diagnostics

Discriminating Clonotypes of Influenza A Virus Genes by Nanopore Sequencing

Translating sanger-based routine DNA diagnostics into generic massive parallel ion semiconductor sequencing

Comprehensive viral enrichment enables sensitive respiratory virus genomic identification and analysis by next generation sequencing